Pharmacovigilance quality assurance is the operational layer that keeps drug safety systems inspection-ready — and when it fails, the consequences are significant. Regulatory authority inspections of pharmacovigilance systems are conducted by the EMA, FDA, MHRA, and national competent authorities on a risk-based schedule. Inspection findings — critical, major, or minor — are publicly disclosed, directly impact marketing authorisation conditions, and in serious cases trigger licence suspension proceedings. The professionals responsible for PV quality systems carry direct accountability for the compliance status of everything the drug safety department produces.

This program builds the complete PV QA competency stack from the ground up. You begin with the regulatory and GVP framework that defines quality requirements — understanding the global regulatory bodies whose inspection standards govern PV operations, the GVP module architecture that specifies quality system requirements, and the documentation standards that create the auditable trail every compliant operation depends on. From there you move through the case-level quality functions: ICSR intake quality, source document review standards, MedDRA coding accuracy verification, narrative quality assessment, submission timeline compliance monitoring, and case closure documentation. The database and systems layer covers E2B(R3) data validation, Oracle Argus Safety quality workflows, data privacy compliance across jurisdictions, and systematic database error identification and resolution. MedDRA quality is trained across every dimension — hierarchy accuracy, complex case coding standards, version transition management, error classification, and correction documentation — because coding quality is the single most audited technical function in any PV inspection.

By the end you carry a complete PV quality audit dossier — live case reviews, compliance gap analysis, non-conformance documentation, corrective action recommendations, and audit report — advisor-reviewed and published to your professional portfolio. In a function where documented QA execution capability is consistently in short supply and directly tied to regulatory risk management, that portfolio signals exactly the seniority and precision that hiring teams are looking for.